Simvastatin is a lipophilic HMG-CoA reductase inhibitor (statin). It is a prodrug hydrolyzed in vivo to its active beta-hydroxy acid, which blocks hepatic cholesterol synthesis and upregulates LDL receptors. It manages hypercholesterolemia and reduces cardiovascular event risks. Its structure contains a hexahydronaphthalene ring linked to a dimethylbutyrate ester and a lactone ring.
Target Simvastatin
Host Species Mouse
Conjugate Unconjugated
Applications ELISA
Antibody Isotype Mouse IgG
For research use only. Not intended for any clinical use.
